Europe — EMA

Novomix 50 Penfill (Insulin Aspart)

Insulin aspart, the active ingredient in Novomix 50 Penfill, is a rapid‑acting insulin analog presented as a solution for subcutaneous injection use. It lowers blood glucose in people with diabetes mellitus.

Insulin Aspart

Request sourcing

Pack/s

What is Insulin Aspart?

GNH USA supplies Novomix 50 Penfill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Insulin Aspart used for?

Novomix 50 Penfill is a rapid‑acting insulin analog that controls blood glucose through the insulin‑dependent pathway. - Type 1 Diabetes Mellitus: Improves post‑prandial glucose control. - Type 2 Diabetes Mellitus: Reduces fasting and post‑prandied but ... - Gestational ....

What are the side effects of Insulin Aspart?

Common

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →